1.
Arch Pediatr
; 26(7): 419-421, 2019 Oct.
Artículo
en Inglés
| MEDLINE
| ID: mdl-31630905
RESUMEN
Nitrous oxide (N2O) is a widely used anesthetic agent. We report two patients with sickle cell disease (SCD) who presented with complications following the use of N2O. Patient 1, a 15-year-old girl, presented severe hyperhomocysteinemia, pancytopenia, vitamin B12 deficiency, and peripheral polyneuropathy after massive use of N2O for pain management. At the 1-year follow-up, hyperhomocysteinemia and B12 deficiency had resolved, but she had persisting mild symptoms of polyneuropathy. Patient 2, a 17-year-old boy, presented only severe hyperhomocysteinemia, only partially corrected by initial B12 supplementation. Careful monitoring of N2O use, especially in patients with SCD, is mandatory to prevent complications.
Asunto(s)
Anemia de Células Falciformes/tratamiento farmacológico , Anestésicos por Inhalación/efectos adversos , Hiperhomocisteinemia/inducido químicamente , Óxido Nitroso/efectos adversos , Enfermedades del Sistema Nervioso Periférico/inducido químicamente , Adolescente , Anestésicos por Inhalación/uso terapéutico , Femenino , Humanos , Hiperhomocisteinemia/diagnóstico , Masculino , Nervio Mediano/efectos de los fármacos , Nervio Mediano/fisiopatología , Óxido Nitroso/uso terapéutico , Enfermedades del Sistema Nervioso Periférico/diagnóstico , Nervio Peroneo/efectos de los fármacos , Nervio Peroneo/fisiopatología , Índice de Severidad de la Enfermedad , Nervio Tibial/efectos de los fármacos , Nervio Tibial/fisiopatología
2.
Infirm Que
; 5(4): 53, 1998.
Artículo
en Francés
| MEDLINE
| ID: mdl-9708174